The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With…

Overview of attention for article published in Frontiers in Molecular Biosciences, June 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (66th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 1 Dimensions

Readers on

mendeley: 11 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 7,394 followers.

RT @kejr35778464: The impact of excluding nonrandomized studies from systematic reviews in rare diseases: https://t.co/CFjJs2O69e Don't f…

13 Apr 2022

Reply Repost Favourite

The impact of excluding nonrandomized studies from systematic reviews in rare diseases: https://t.co/CFjJs2O69e Don't forget: "signs - RECOGNIZE THE SIGNS". Date: 05/17/2022 | 18:30 - 20:00 | LIVE webinar. Link to registration: https://t.co/7R7wPjCQPx

13 Apr 2022

Reply Repost Favourite

New Research: The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases: “The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With Mucopolysaccharidosis” https://t.co/6bj1uf

16 Jul 2021

Reply Repost Favourite

The Impact of Excluding Nonrandomized Studies From Systematic Reviews in Rare Diseases:The Example of Meta-Analyses Evaluating the Efficacy and Safety of Enzyme Replacement Therapy in Patients With ... https://t.co/mVryJZ1RoZ #hvhebron #onco #medint [Text

12 Jul 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.